CoChat

INTERNATIONAL GUIDELINES FOR THE SELECTION OF LUNG TRANSPLANT CANDIDATES

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

More than 6400 lung transplants have been performed since the first successful operations in the early 1980s. (1) Lung transplant programs now exist in many countries. Internationally, the number of donor organs available is far fewer than the number of patients with end-stage lung disease. Because of this many candidates die on the waiting list and the average wait to receive a donor organ may approach two years. (2) Overall survivals are between 60 and 65 per cent at two years and approximately 40 per cent at five years. (1) Considering the resource limitations and the importance of assuring optimum outcomes, we believe that international guidelines for selection of appropriate candidates for lung transplant will ensure a fair distribution of donor organs. Transplant physicians and surgeons representing the International Society of Heart and Lung Transplantation, the American Society of Transplant Physicians, the American Thoracic Society, the European Respiratory Society, and the Thoracic Society of Australia and New Zealand have agreed on the information in the following document as acceptable guidelines for candidates for lung transplantation. Our aim is that this document will assist physicians throughout the world who are treating patients with pulmonary diseases to identify potential candidates for lung transplantation. This document is divided into two sections. The first describes general health guidelines which all candidates for lung transplantation should meet; the second describes disease specific exercise or lung function criteria which are generally felt to identify patients whose poor prognosis from their underlying disease justify transplantation. Candidates for either live donor organs or cadaver donor organs should meet the same selection criteria. In all cases it must be remembered that these guidelines are a general statement and that individual patients might have specific circumstances which do not meet all guidelines yet would be acceptable transplant candidates. Lung transplantation remains a developing field within pulmonary medicine and thoracic surgery. It is anticipated that with increasing experience and knowledge the state of the art will change and these guidelines will require review and modification. GENERAL GUIDANCE FOR CANDIDATE SELECTION FOR LUNG TRANSPLANTATION Physicians evaluating patients for lung transplantation should ensure that the patient has received or is receiving maximum, optimal medical therapy for his disease but nevertheless has declining function. In general candidates should have chronic disease for which no further medical or surgical therapy is available and survival is limited; lung transplantation is rarely an option for acutely, critically ill patients. Comorbid medical conditions should also be optimally treated in transplant candidates and routine preventive medicine measures (such as mammograms, Pap smears, and colon cancer screening) be completed where appropriate. Older patients have a significantly worse survival than younger patients (1). The following guidelines are suggested. Age limits: Heart-lung transplants ∼ 55 years Single lung transplants ∼ 65 years Bilateral lung transplants ∼ 60 years GENERAL MEDICAL CONDITIONS WHICH IMPACT ON ELIGIBILITY FOR LUNG TRANSPLANTATION The following are a list of general medical conditions which are felt to impact on the long-term outcome of lung transplant recipients. Medical or psychosocial treatment to address these issues should be instituted when appropriate in patients who do not currently, but may ultimately, meet the criteria for lung transplantation. However, in most cases, referral should not be delayed while patients are undergoing corrective treatment. Other medical conditions which, when they have not resulted in organ damage, are generally acceptable in candidates for lung transplantation-e.g., systemic hypertension, diabetes mellitus, peptic ulcer disease, should also be optimally treated and well-controlled. In the presence of any comorbid medical condition with the potential for end organ damage, a careful search should be made for evidence of organ dysfunction. Symptomatic osteoporosis is a relative contraindication to transplantation and the potential risk to acceptable long term outcome should be assessed on a case by case basis. (3) symptomatic and asymptomatic significant disease requires treatment which should be initiated prior to transplant. Patients should be fully investigated and followed by appropriate objective measures, i.e. bone densitometry. Severe musculoskeletal disease affecting the thorax, e.g., kyphoscoliosis, is a relative contraindication and progressive neuromuscular disease is an absolute contraindication to lung transplantation. Current use of corticosteroids is not a contraindication to transplantation; however, all attempts to discontinue these drugs or at least reduce the dose to≤20 mg. per day prednisolone or prednisone should be made. (4) Nutritional issue

Overview

Integrity signals

Registry

Crossref · 10.1097/00007890-199810150-00033

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Research works printed but not linked: 5

  1. Hosenpud, 1997, J Heart Lung Transplant, 16, 691
  2. Sharples, 1993, J Heart Lung Transplant, 12, 669
  3. Grady, 1996, J Heart Lung Transplant, 15, 863
  4. Bando, 1995, J Heart Lung Transplant, 14, 692
  5. Hopkins, 1996, J Heart Lung Transplant, 15, 100

Cited by

See all 644

Metadata

Authors
Maurer, J. R., Frost, A. E., Estenne, M., Higenbottam, T., & Glanville, A. R.
Affiliations
American Society of Transplantation (US)
Venue
Transplantation
Published
1998-10
Volume
66
Issue
7
Pages
951-956
ISSN
0041-1337 (ISSN-L)
OpenAlex
W1972718711
Cited by
562
References
39
Citations by year
2025: 7 · 2024: 2 · 2023: 6 · 2022: 7 · 2021: 12 · 2020: 15 · 2019: 8 · 2018: 10 · 2017: 14 · 2016: 10 · 2015: 17 · 2014: 34 · 2013: 21 · 2012: 25
FWCI
18.12
Type
journal article
Language
en
Open access
closed
Locations
  • Transplantation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Organ Donation and Transplantation
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
Keywords
lung transplantation, transplant candidate selection, end-stage lung disease, organ allocation, exercise capacity, lung function, age limits, comorbidities, International Society for Heart and Lung Transplantation, international consensus guidelines, waitlist mortality, donor shortage, elderly patients, chronic obstructive pulmonary disease, interstitial lung disease
MeSH terms
Humans, Lung Transplantation, Patient Selection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: INTERNATIONAL GUIDELINES FOR THE SELECTION OF LUNG TRANSPLANT CANDIDATES. https://app.cochat.ai/papers/10.1097/00007890-199810150-00033
The paper
Maurer, J. R., Frost, A. E., Estenne, M., Higenbottam, T., & Glanville, A. R. (1998). INTERNATIONAL GUIDELINES FOR THE SELECTION OF LUNG TRANSPLANT CANDIDATES. Transplantation. https://doi.org/10.1097/00007890-199810150-00033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.